Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease lupus erythematosus
Phenotype C0042373|vascular disease
Sentences 14
PubMedID- 22401784 Subclinical vascular disease in patients with systemic lupus erythematosus: the additive deleterious effect of the antiphospholipid syndrome.
PubMedID- 24470118 25-hydroxyvitamin d and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohort.
PubMedID- 20191526 Objective: to investigate the association between physical activity, functional activity of high-density lipoprotein (hdl), and subclinical cardiovascular disease in patients with systemic lupus erythematosus (sle).
PubMedID- 23612403 [cerebrovascular disease in women with systemic lupus erythematosus].
PubMedID- 25732129 Results: plasma sucrose non-fermenting ampk related kinase and pentraxin 3 concentrations were increased in systemic lupus erythematosus cases with cardiovascular disease compared to systemic lupus erythematosus controls and healthy controls (p < 0.0001).
PubMedID- 23052654 Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosus.
PubMedID- 23942785 Increased serum levels of s100a8/a9 and s100a12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus.
PubMedID- 23886740 Background and purpose: antiphospholipid syndrome may affect the incidence and pathogenesis of cerebrovascular diseases in patients with systemic lupus erythematosus.
PubMedID- 21360503 Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation.
PubMedID- PMC3467499 Our study investigates whether serum α-clfa may be a biomarker for subclinical cardiovascular disease (cvd) in patients with systemic lupus erythematosus (sle).
PubMedID- 22126778 Objective: to investigate the prevalence of cardiovascular diseases (cvd) in patients with systemic lupus erythematosus (sle) and estimate the associated risk factors for cvd.
PubMedID- 24299152 Altered levels of fxiia-serpin complexes in systemic lupus erythematosus (sle) patients with previous vascular disease (vd).
PubMedID- 25379191 Adverse pregnancy outcomes and subsequent risk of cardiovascular disease in women with systemic lupus erythematosus.
PubMedID- 24787906 Cardiometabolic and immune factors associated with increased common carotid artery intima-media thickness and cardiovascular disease in patients with systemic lupus erythematosus.

Page: 1